Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Ruchika Sharma27 Feb 2025 3:17 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...

CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibbs Mavacamten Study

Bristol Myers Squibb application for Opdivo Plus Yervoy for MSI-H/ dMMR colorectal cancer accepted by USFDA

Ruchika Sharma27 Feb 2025 12:46 PM IST

Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental biologics license application...

Sanofi Rilzabrutinib earns orphan designation in EU for IgG4 related disease

Sanofi Sarclisa combo gets Japanese nod for newly diagnosed multiple myeloma

Ruchika Sharma27 Feb 2025 11:30 AM IST

Paris: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with...

Emcure Pharma Gets CDSCO Panel Nod for Phase III Trial of Semaglutide in Chronic Weight Management

Emcure Pharma Pune facility gets 2 USFDA observations

Ruchika Sharma26 Feb 2025 3:14 PM IST

Pune: Emcure Pharmaceuticals Limited has announced that the Company has received two observations in Form 483 from the United States Food and...

USFDA issues EIR for Dr Reddy's Labs Hyderabad facility

Ruchika Sharma26 Feb 2025 2:30 PM IST

Hyderabad: Dr Reddy's Labs has announced that the Company has received the Establishment Inspection Report (EIR) from the United States Food...

AstraZeneca Imfinzi gets USFDA priority review

Caplin Sterils gets USFDA nod for Eye Drop for reduction of elevated intraocular pressure

Ruchika Sharma26 Feb 2025 1:30 PM IST

Chennai: Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval by the United...

Marksans Pharma UK arm gets marketing nod for Ibuprofen, Paracetamol Film-coated Tablets

Ruchika Sharma26 Feb 2025 12:43 PM IST

Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary in UK RelonchemLimited has received Marketing...

Gland Pharma Pashamylaram facility receives GMP compliance certificate from Danish Medicines Agency

Gland Pharma gets 3 USFDA observations for Visakhapatnam facility

Ruchika Sharma26 Feb 2025 11:30 AM IST

Hyderabad: Gland Pharma has announced that the United States Food and Drug Administration (US FDA) has concluded an inspection with three observations...

Cadila Pharma unveils advanced pharmaceutical warehouse

Ruchika Sharma26 Feb 2025 10:30 AM IST

Ahmedabad: Cadila Pharmaceuticals has announced the expansion of its state-of-the-art pharmaceutical warehouse to bolster efficiency,...

GSK buys IDRx for up to USD 1.15 billion

Ruchika Sharma25 Feb 2025 2:33 PM IST

London: GSK plc has announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated...

Former FDA director Patrizia Cavazzoni rejoins Pfizer

Ruchika Sharma25 Feb 2025 1:30 PM IST

New York: Pfizer Inc. has announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice President.In...

Biocon Biologics expands biosimilar insulin portfolio with USFDA nod of Kirsty

Biocon Biologics unveils Yesintek biosimilar to Stelara in US

Ruchika Sharma25 Feb 2025 12:31 PM IST

YESINTEK will be available in all the same formulations currently provided by Stelara.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok